Changes in hepatic fatty acid synthesis following glucagon injections in vivo.
D001275:ATP Citrate (pro-S)-Lyase / Q000378:metabolism; D000103:Acetyl-CoA Carboxylase / Q000037:antagonists & inhibitors; D000818:Animals; D002245:Carbon Dioxide / Q000378:metabolism; D064429:Fatty Acid Synthases / Q000378:metabolism; D005227:Fatty Acids / Q000096:biosynthesis*; D005934:Glucagon / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism; D005990:Glycerol / Q000096:biosynthesis; D007521:Isocitrate Dehydrogenase / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008291:Malate Dehydrogenase / Q000378:metabolism; D008297:Male; D051381:Rats; D013997:Time Factors
D005227:Fatty Acids; D002245:Carbon Dioxide; D005934:Glucagon; D008291:Malate Dehydrogenase; D007521:Isocitrate Dehydrogenase; D064429:Fatty Acid Synthases; D001275:ATP Citrate (pro-S)-Lyase; D000103:Acetyl-CoA Carboxylase; D005947:Glucose; D005990:Glycerol